MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.040
+0.020
+1.96%
Pre Market: 1.050 +0.01 +0.93% 04:57 10/06 EDT
OPEN
1.030
PREV CLOSE
1.020
HIGH
1.050
LOW
1.000
VOLUME
1.55K
TURNOVER
0
52 WEEK HIGH
2.725
52 WEEK LOW
0.9700
MARKET CAP
352.67M
P/E (TTM)
-4.0832
1D
5D
1M
3M
1Y
5Y
1D
Transcript: Ocugen Q2 2026 Earnings Conference Call
Benzinga · 48m ago
Weekly Report: what happened at OCGN last week (0928-1002)?
Weekly Report · 23h ago
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026
Seeking Alpha · 3d ago
Ocugen Inc. Stock Sheds 5.5%, Underperforms Market
Dow Jones · 5d ago
Analyst Maintains Buy Rating on Ocugen as OCU400’s Early Revenue Pathway and Phase 3 Upside Support Unchanged $11 Price Target
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Quince Therapeutics (QNCX), Vir Biotechnology (VIR) and Ocugen (OCGN)
TipRanks · 6d ago
Ocugen Inc. Stock Rallies 5.8%, Outperforms Market
Dow Jones · 6d ago
Ocugen to Participate in Upcoming October Investor and Industry Conferences
Barchart · 09/29 06:02
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.